| JNJ Stock | | | EUR 139.96 0.94 0.67% |
Director
Dr. Mary C. Beckerle, Ph.D., is an Independent Director of the Company. She has served as CEO of Huntsman Cancer Institute at the University of Utah since 2006. She is the associate vice president for cancer affairs and a distinguished professor of biology and oncological sciences at the University of Utah. Dr. Beckerle joined the faculty of the University of Utah in 1986 and currently holds the Jon M. Huntsman Presidential Endowed Chair. Dr. Beckerle has served on the National Institute of Health Advisory Committee to the Director, on the Board of Directors of the American Association for Cancer Research, as president of the American Society for Cell Biology, and as the Chair of the American Cancer Society Council for Extramural Grants. She currently serves on a number of scientific advisory boards, including the Medical Advisory Board of the Howard Hughes Medical Institute, and the Scientific Advisory Boards of the National Center for Biological Sciences at the Tata Institute of Fundamental Research in India, the Mechanobiology Institute in Singapore, and the Dana FarberHarvard Cancer Center. Dr. Beckerle held a Guggenheim Fellowship at the Curie Institute in Paris, received the Utah Governors Medal for Science and Technology in 2001, the Sword of Hope Award from the American Cancer Society in 2004 and is an elected Fellow of the American Academy of Arts and Sciences and the American Philosophical Society. Dr. Beckerle was also named a National Association of Corporationrationrate Directors Governance Fellow in 2012. since 2015.
Johnson Johnson (JNJ) is traded on Berlin Exchange in Germany and employs 33 people.
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| A Washington, Independent Director | |
| Jennifer Doudna, Independent Director | |
| Alex Gorsky, Chairman of the Board, Chief Executive Officer | |
| Michael Sneed, Executive Vice President - Global Corporate Affairs and Chief Communication Officer | |
| Ashley McEvoy, Executive Vice President - Worldwide Chairman, Medical Devices | |
| Marillyn Hewson, Independent Director | |
| Ronald Williams, Independent Director | |
| Kathryn Wengel, Executive Vice President Chief Global Supply Chain Officer | |
| Michael Ullmann, Executive Vice President, General Counsel | |
| Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | |
| D Davis, Independent Director | |
| Hubert Joly, Independent Director | |
| Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | |
| Anne Mulcahy, Lead Independent Director | |
| Mary Beckerle, Independent Director | |
| Joseph Wolk, Chief Financial Officer, Executive Vice President | |
| Thibaut Mongon, Executive Vice President Worldwide Chairman, Consumer | |
| Ian Davis, Independent Director | |
| Paulus Stoffels, Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group | |
| Mark McClellan, Independent Director | |
| Charles Prince, Independent Director | |
| Peter Fasolo, Chief Human Resource Officer, Executive Vice President | |
| Mark Weinberger, Independent Director | |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company
management, corporate governance, and ethical practices play a significant role. A
comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock.
Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock: Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For information on how to trade Johnson Stock refer to our
How to Trade Johnson Stock guide.
You can also try the
Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.